N/A
Completed N=730
Mission Reconnect-Veterans and Their Partners to Manage Pain and PTSD (MR)
Source: ClinicalTrials.gov NCT03593772 ↗Enrolled (actual)
730
Serious AEs
0.0%
Results posted
Aug 2024
Primary outcomePrimary: Pain Outcomes Questionnaire (POQ) — 102.32; 94.9863; 6.2006; 6.1251 Units on a scale — p=0.0535
Summary
This project is responsive to Rehabilitation Research and Development's (RR&D) current special areas of interest for non-pharmacological activity-based interventions for chronic pain impacting pain reduction, function and quality of life. This project aligns with the VA mandate for complementary and integrative health (CIH) care for Veterans and their families. CIH complements traditional care for Veterans managing chronic conditions, such as chronic pain and PTSD. Mission Reconnect (MR) is a user-driven, dyadic, CIH self-care management program delivered remotely that teaches techniques the Veteran/partner dyad can use to reduce pain, anxiety and stress, promote well-being and improve relationship quality. The research goal is to evaluate MR as an approach to manage chronic pain and PTSD symptoms, for potential subsequent implementation. This study will possibly provide a model for establishing remote access and sustainable implementation of CIH within VA.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Pain Outcomes Questionnaire (POQ) |
102.32; 94.9863; 6.2006; 6.1251; 21.4893; 20.2530 | 0.0535 |
| SECONDARY Pain, Stress and Tension Likert |
3.3904; 3.3230; 3.1728; 3.0601; 3.4061; 3.2474 | 0.1924 |
| SECONDARY Defense and Veterans Pain Rating Scale |
5.8062; 5.8431; 6.1319; 6.0125; 5.9953; 5.7385 | 0.1622 |
| SECONDARY PTSD: Posttraumatic Checklist |
43.5759; 41.5687 | 0.4808 |
| SECONDARY Quality of Life Short-form (SF12) |
24.1845; 24.0067; 43.5871; 44.3803 | 0.9692 |
| SECONDARY Sleep Quality: Pittsburgh Sleep Quality Index (PSQI) |
1.9406; 1.8286; 2.0332; 2.0296; 0.8399; 1.0488 | 0.5642 |
| SECONDARY Compassion for Self and Others Scales |
5.5055; 6.1296; 5.4667; 5.9148; 2.7177; 3.2624 | 0.6679 |
Eligibility Criteria
Inclusion Criteria
- English-speaking Veterans with chronic musculoskeletal pain.
- Veteran is considered to have chronic musculoskeletal pain if he or she meeting either of two validated criteria:
- (1) Having 2+ occurrences of any of targeted musculoskeletal ICD-9-CM codes "likely to represent chronic pain" recorded at visits separated by at least 30 days within past six months
- (2) Having high impact chronic pain = 2+ occurrences of targeted musculoskeletal ICD-9-CM codes separated by at least 30 days within the past six months previous to study recruitment and two or more pain scores greater than or equal to 4 separated by at least 30 days within past six months.
- For pain scores, the investigators will use the 0-10 numeric pain rating scale that is routinely collected at the VA.
- The investigators will count two ICD-9-CM codes or pain scores recorded on the same day as one code/score.
- Veteran is considered to have PTSD if he or she has a flag in his/her record indicating confirmed condition by the VA Compensation and Benefits program, has at least two outpatient visits in the year with the primary diagnosis being listed as PTSD (ICD-9-CM code 309.81) and/or had PTSD listed on the problem list], Veteran must also have PTSD (defined by PTSD diagnosis-ICD-9-CM 309.81), the ability to access and use an electronic platform (e.g. Mobile device, internet, DVD) for MR delivery, with a willing partner to also participate in the study and MR program.
Exclusion Criteria
- Moderate to severe traumatic brain injury (TBI)
- Diagnosis or documented treatment for psychosis in previous 6 months
- Currently in substance use disorder treatment
- Non-English speaking
- Visual, hearing, cognitive impairment that prevent participation or ability to consent
- And/or lack of access to internet service
- These individuals will be excluded due to medical, language, and technology access issues that would prevent safe and full study participation.
- Pain and PTSD treatment will not be factored as an inclusion/exclusion criteria but will be evaluated as covariates.
- Potential participants who screen for aggression or violence will also be excluded from study.
Data sourced from ClinicalTrials.gov (NCT03593772). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.